Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out

Circulation. 2006 May 2;113(17):2128-34; discussion 2151. doi: 10.1161/CIRCULATIONAHA.105.611350.

Authors

Benjamin M Scirica¹, David A Morrow

Affiliation

¹ TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

PMID: 16651484
DOI: 10.1161/CIRCULATIONAHA.105.611350

No abstract available

Publication types

Review

MeSH terms

Animals
Apolipoproteins E / physiology
Atherosclerosis / blood
Atherosclerosis / etiology*
Biomarkers
C-Reactive Protein / analysis
C-Reactive Protein / antagonists & inhibitors
C-Reactive Protein / toxicity*
Endothelial Cells / drug effects
Humans
Models, Animal

Substances

Apolipoproteins E
Biomarkers
C-Reactive Protein